Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
States
/
New Hampshire

Product Recalls in New Hampshire

All product recalls affecting New Hampshire.

Includes nationwide recalls (tagged “Nationwide”) and recalls with New Hampshire in the distribution area.

Get alerts for New Hampshire

Showing 3021–3040 of 33648 recalls

Onasti Toddler Tower Stools – Fall Risk (2025)

This recall involves Onasti-branded toddler stools. The plastic, foldable, triangular-shaped tower stools were sold in beige/white, blue/gray, green, gray/white, light blue and pink. They measure about 25 inches long, 24 inches wide and 32 inches tall, and have handles and an adjustable platform that can be raised or lowered from two to three steps. The Onasti logo appears on the warning label on the side of the stools.

High

CPSCMar 13, 2025Nationwide

Diltiazem Extended-Release Capsules (Glenmark) – CGMP Deviations (2025)

CGMP Deviations

Stay Informed

Product Recalls in New Hampshire

Onasti Toddler Tower Stools – Fall Risk (2025)

Diltiazem Extended-Release Capsules (Glenmark) – CGMP Deviations (2025)

Levetiracetam Injection (Dr. Reddy's) – Labeling Error (2025)

Propafenone Extended-Release Capsules (Glenmark) – CGMP Deviations (2025)

Pravastatin Sodium Tablets (Glenmark) – CGMP Deviations (2025)

Fluphenazine Tablets (Glenmark) – CGMP Deviations (2025)

Fenofibrate Capsules (Glenmark) – CGMP Deviations (2025)

Cetirizine Hydrochloride Tablets 10mg (Glenmark) – CGMP Issues (2025)

Rufinamide Tablets 200mg (Glenmark) – CGMP Issues (2025)

Lacosamide Tablets 150mg (Glenmark) – CGMP Issues (2025)

Lacosamide Tablets 100mg (Glenmark) – CGMP Issues (2025)

Carvedilol Tablets 12.5mg (Glenmark) – CGMP Issues (2025)

Propafenone Extended-Release 225mg (Glenmark) – CGMP Issues (2025)

Lacosamide Tablets 200mg (Glenmark) – CGMP Issues (2025)

Clindamycin Hydrochloride Capsules 300mg (Glenmark) – CGMP Issues (2025)

Lacosamide Tablets 50mg (Glenmark) – CGMP Issues (2025)

Propafenone Extended-Release 225mg (Glenmark) – CGMP Issues (2025)

Voriconazole Tablets 200mg (Glenmark) – CGMP Deviations (2025)

Fluphenazine Hydrochloride Tablets 2.5mg (Glenmark) – CGMP Deviations (2025)

Propafenone Extended-Release 325mg (Glenmark) – CGMP Issues (2025)

Other States